The majority of #breastcancer cases are hormone receptor positive. We can target these cancers by preventing oestrogen from binding to the cancer cells, which inhibits cell growth. #BCAM #BCSMpic.twitter.com/kjnhhRhOoB

14:12 EDT 5 Oct 2018 | AztraZeneca

The majority of #breastcancer cases are hormone receptor positive. We can target these cancers by preventing oestrogen from binding to the cancer cells, which inhibits cell growth. #BCAM #BCSM pic.twitter.com/kjnhhRhOoB

More From BioPortfolio on "The majority of #breastcancer cases are hormone receptor positive. We can target these cancers by preventing oestrogen from binding to the cancer cells, which inhibits cell growth. #BCAM #BCSMpic.twitter.com/kjnhhRhOoB"